Page 1 of Clinical Trials for "Topoisomerase Inhibitors", 993 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer
Last Updated: April 12, 2012
Condition(s): Small Cell Lung Cancer
2
Active, not recruiting
Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Last Updated: March 8, 2012
Condition(s): Lung Cancer
3
Terminated
A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose and Repeat Escalating Oral Doses of GSK945237; the Effect of Linezolid on Hematology Safety Parameters; and the Effects of GSK945237 and Moxifloxacin on QTc.
Last Updated: May 12, 2011
Condition(s): Infections, Bacterial
4
Recruiting
A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas
Last Updated: March 21, 2012
Condition(s): Neoplasms; Lymphoma
5
Completed
Irinotecan With Docetaxel in Treating Patients With Recurrent or Metastatic Non-Small Cell Lung Cancer
Last Updated: July 23, 2008
Condition(s): Lung Cancer
6
Completed
SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid Tumors
Last Updated: February 6, 2010
Condition(s): Unspecified Adult Solid Tumor, Protocol Specific
7
Completed
Study of OSI-211 vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer
Last Updated: October 18, 2011
Condition(s): Ovarian Neoplasms
8
Completed
Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma
Last Updated: January 26, 2012
Condition(s): Neuroblastoma
9
Completed
Pixantrone (BBR 2778) in Patients With Refractory Acute Myelogenous Leukemia (AML)
Last Updated: August 21, 2007
Condition(s): Acute Myelogenous Leukemia
10
Completed
Sequential Versus Combination Chemotherapy in Advanced Colorectal Carcinoma
Last Updated: September 5, 2008
Condition(s): Advanced Colorectal Cancer
11
Active, not recruiting
Second-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLC
Last Updated: March 10, 2008
Condition(s): Non-Small Cell Lung Cancer
12
Active, not recruiting
Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Last Updated: February 24, 2011
Condition(s): Colorectal Cancer
13
Terminated
A Study of MK1775 in Combination With Topotecan/Cisplatin in Patients With Cervical Cancer (1775-008)
Last Updated: June 22, 2011
Condition(s): Cervical Cancer
14
Completed
Irinotecan in Treating Patients With Recurrent Malignant Glioma
Last Updated: July 23, 2008
Condition(s): Brain and Central Nervous System Tumors
15
Completed
Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver
Last Updated: March 7, 2012
Condition(s): Colorectal Cancer; Metastatic Cancer
16
Active, not recruiting
Erlotinib and Irinotecan in Treating Patients With Advanced Solid Tumors
Last Updated: May 20, 2010
Condition(s): Unspecified Adult Solid Tumor, Protocol Specific
17
Completed
Weekly Topotecan in the First-line Treatment of Elderly Patients With Small Cell Lung Cancer
Last Updated: July 27, 2010
Condition(s): Lung Cancer
18
Active, not recruiting
Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies
Last Updated: June 22, 2011
Condition(s): Solid Tumor
19
Active, not recruiting
CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC)
Last Updated: March 1, 2012
Condition(s): Lung Cancer
20
Recruiting
Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme
Last Updated: January 31, 2012
Condition(s): Malignant Gliomas

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?intr=%22Topoisomerase+Inhibitors%22

Page 1 of Clinical Trials for "Topoisomerase Inhibitors", 993 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About